← Browse by Condition
Medical Condition
colorectal adenocarcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT06640166 Phase 2
Recruiting
Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.
Enrollment
25 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers...
NCT06342401
Recruiting
Early Onset Colorectal Cancer Detection
Enrollment
400 pts
Location
United States, Italy...
Sponsor
City of Hope Medical Center